Please Note:
This profile was automatically generated using 22 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 22 references found on the Internet. This information has not been verified. Learn more...
Employment History
View...View all 22 references Web References
-
1. www.dimag.com
www.dimag.com/pacswebcardio/pr - [Cached]Published on: 5/11/2007 Last Visited: 5/12/2007
Louis Brenner, MD, Senior Vice President of Advanced Magnetics, will present an overview of the company on Tuesday, May 22, at 1:00 pm ET. -
2. www.sec.gov
www.sec.gov/Archives/edgar/dat - [Cached]Published on: 2/6/2007 Last Visited: 3/18/2007
0001389500 BRENNER LOUIS MD C/O ADVANCED MAGNETICS, INC. 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CAMBRIDGE MA 02140 0 1 0 0 Senior Vice President -
3. Advanced Magnetics Announces the Appointments of Louis Brenner, MD as Senior Vice President and Mohammed A. Salem, PhD as Vice President of Regulatory Affairs
www.prnewswire.com/cgi-bin/sto - [Cached]Published on: 9/11/2006 Last Visited: 9/17/2006
Advanced Magnetics Announces the Appointments of Louis Brenner, MD as Senior Vice President and Mohammed A. Salem, PhD as Vice President of Regulatory Affairs
...
Advanced Magnetics Announces the Appointments of Louis Brenner, MD as Senior Vice President and Mohammed A. Salem, PhD as Vice President of Regulatory Affairs
...
CAMBRIDGE, Mass., Sept. 11 /PRNewswire-FirstCall/ -- Advanced Magnetics, Inc. (Nasdaq: AMAG) today announced the appointment of Louis Brenner, MD as Senior Vice President and the appointment of Mohammed A. Salem, PhD as Vice President of Regulatory Affairs.
...
Dr. Brenner joins Advanced Magnetics from his position as Senior Director of Business Development for the Renal and Transplantation Units of Genzyme Corporation.
...
In this new position, Dr. Brenner will assume responsibility for the success of the ferumoxytol program, including all aspects of the submission of the New Drug Application for ferumoxytol as an intravenous iron replacement therapeutic for the treatment of anemia in dialysis-dependent (DD) and non-dialysis dependent (NDD) chronic kidney disease patients (CKD) along with the planning and execution of subsequent indications for ferumoxytol. Additionally, Dr. Brenner will be responsible for building the Medical Affairs group at Advanced Magnetics.
...
"We are pleased that two individuals like Lou and Mohammed have agreed to join our Advanced Magnetics team," stated Brian J.G. Pereira, MD, President of Advanced Magnetics, Inc.
...
"We are excited to have someone of Lou's experience in nephrology to aid us in bringing ferumoxytol to anemic CKD patients."

